Evaluation of topical photodynamic therapy of mammary carcinoma with an experimental gel containing liposomal hydroxyl-aluminium phthalocyanine

Anticancer Research

Volumn 32, Issue 9, 2012, Pages 3769-3774

  Sutoris, Karol ^a,b   Vetvicka, David ^a,c   Horak, Ladislav ^b   Benes, Jiri ^a   Nekvasil, Milos ^d   Jezek, Petr ^d   Zadinova, Marie ^a   Pouckova, Pavla ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c CancerTech Ltd   (Czech Republic)

^d INSTITUTE OF PHYSIOLOGY   (Czech Republic)

Author keywords

Liposomal photosensitizer; MDA MB 231 cells; Photodynamic therapy; Phthalocyanine

Indexed keywords

AMINOLEVULINIC ACID METHYL ESTER; HYDROXYL ALUMINIUM PHTHALOCYANINE; LIPOSOME; PHOTOSENSITIZING AGENT; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CANCER GROWTH; CANCER REGRESSION; CONTROLLED STUDY; DRUG EFFICACY; IN VIVO STUDY; MOUSE; NONHUMAN; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADENOCARCINOMA; ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; COORDINATION COMPLEXES; FEMALE; GELS; HUMANS; INDOLES; LIPOSOMES; MALE; MICE; MICE, NUDE; ORGANOMETALLIC COMPOUNDS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84867006341     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. Agostinis P, Berg K, Cengel KA, Foster TH, Girotti AW, Gollnick SO, Hahn SM, Hamblin MR, Juzeniene A, Kessel D, Korbelik M, Moan J, Mroz P, Nowis D, Piette J, Wilson BC and Golab J: Photodynamic therapy of cancer: An update. CA Cancer J Clin 61: 250-281, 2011.
2. Moriwaki SI, Misawa J, Yoshinari Y, Yamada I, Takigawa M and Tokura Y: Analysis of photosensitivity in Japanese cancer-bearing patients receiving photodynamic therapy with porfimer sodium (Photofrin). Photodermatol Photoimmunol Photomed 17: 241-243, 2001. (Pubitemid 32834293)
3. Oleinick NL, Morris RL and Belichenko I: The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem Photobiol Sci 1: 1-21, 2002. (Pubitemid 37069701)
4. Kammerer R, Buchner A, Palluch P, Pongratz T, Oboukhovskij K, Beyer W, Johansson A, Stepp H, Baumgartner R and Zimmermann W: Induction of immune mediators in glioma and prostate cancer cells by non-lethal photodynamic therapy. PLoS One 6: e21834, 2011.
5. Nekvasil M, Zadinova M, Tahotna L, Zackova M, Pouckova P and Jezek P: Optimum modality for photodynamic therapy of tumors: Gels containing liposomes with hydrophobic photosensitizers. Drug Dev Res 5: 235-252, 2007. (Pubitemid 350223934)
6. Zeitouni NC, Oseroff AR and Shieh S: Photodynamic therapy for nonmelanoma skin cancers. Current review and update. Mol Immunol 39: 1133-1136, 2003. (Pubitemid 36776569)
7. Bilgin MD, Elçin AE and Elçin YM: Topical use of liposomal copper palmitate formulation blocks porphyrin-induced photosensitivity in rats. J Photochem Photobiol 80: 107-114, 2005. (Pubitemid 40984409)
8. Annemans L, Caekelbergh K, Roelandts R, Boonen H, Leys C, Nikkels AF, van Den Haute V, van Quickenborne L, Verhaeghe E and Leroy B: Real-life practice study of the clinical outcome and cost-effectiveness of photodynamic therapy using methyl aminolevulinate (MAL-PDT) in the management of actinic keratosis and basal cell carcinoma. Eur J Dermatol 18: 539-546, 2008.
9. Detty MR, Gibson SL and Wagner SJ: Current clinical and preclinical photosensitizers for use in photodynamic therapy. J Med Chem 47: 3897-3915, 2004. (Pubitemid 38970949)
10. Kaestner L, Cesson M, Kassab K, Christensen T, Edminson PD, Cook MJ, Chambrier I and Jori G: Zinc octa-n-alkyl phthalocyanines in photodynamic therapy: Photophysical properties, accumulation and apoptosis in cell cultures, studies in erythrocytes and topical application to Balb/c mice skin. Photochem Photobiol Sci 2: 660-667, 2003. (Pubitemid 41646662)
11. Kalka K, Ahmad N, Criswell T, Boothman D and Mukhtar H: Up-regulation of clusterin during phthalocyanine 4 photodynamic therapy-mediated apoptosis of tumor cells and ablation of mouse skin tumors. Cancer Res 60: 5984-5987, 2000.
12. Kyriazi M, Alexandratou E, Yova D, Rallis M and Trebst T: Topical photodynamic therapy of murine non-melanoma skin carcinomas with aluminum phthalocyanine chloride and a diode laser: Pharmacokinetics, tumor response and cosmetic outcomes. Photodermatol Photoimmunol Photomed 24: 87-94, 2008. (Pubitemid 351436830)
13. Hopper C: Photodynamic therapy: A clinical reality in the treatment of cancer. Lancet Oncol 1: 212-219, 2000.
14. Castano AP, Deminova TN and Hamblin MR: Mechanisms in photodynamic therapy: Part one - photosensitizers, photochemistry and cellular localization. Photodiag Photodyn Ther 4: 279-293, 2004. (Pubitemid 40460316)
15. Foley P: Clinical efficacy of methyl aminolevulinate (Metvix) photodynamic therapy. J Dermatolog Treat 14: 15-22, 2003.
16. Czech Patent No. 298978, Liposomal phthalocyanine gel preparation for photodynamic therapy of tumors and its procedure of preparation. Czech Office of Industrial Ownership, Prague, 2008.
17. Allison RR, Bagnato VS, Cuenca R, Downie GH and Sibata CH: The future of photodynamic therapy in oncology. Future Oncol 2: 53-71, 2006.
18. Allison RR, Sibata C, Downie GH and Cuenca RE: Photodynamic therapy of the intact breast. Photodiag Photodyn Ther 3: 139-146, 2006. (Pubitemid 44143039)
19. Roche JVE, Whitehurst C, Watt P, Moore JV and Krasner N: Photodynamic therapy (PDT) of gastrointestinal tumours: A new light delivery system. Laser Med Sci 13: 137-142, 1998. (Pubitemid 28347049)
20. Kimura H, Lee C, Hayashi K, Yamauchi K, Yamamoto N, Tsuchiya H, Tomita K, Bouvet M and Hoffman RM: UV light killing efficacy of fluorescent protein-expressing cancer cells in vitro and in vivo. J Cell Biochem 110: 1439-1446, 2010.
21. Zhang Q, Fan H, Shen J, Hoffman RM and Xing HR: Human breast cancer cell lines co-express neuronal, epithelial, and melanocytic differentiation markers in vitro and in vivo . PLoS One 5: e9712, 2010.
22. Hoffman RM: Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: A bridge to the clinic. Invest New Drugs 17: 343-359, 1999.